查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1617163

到 2030 年中央静脉导管市场预测：按产品、特性、设计、成分、最终用户和地区进行的全球分析

Central Venous Catheter Market Forecasts to 2030 - Global Analysis By Product (Tunneled Catheters and Non-Tunneled Catheters), Property, Design, Composition, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球中央静脉导管市场规模为 28.61 亿美元，预计到 2030 年将达到 46.935 亿美元，预测期内复合年增长率为 8.6%。中央静脉导管(CVC) 是一种插入颈部、胸部或鼠蹊部大静脉的医疗设备，用于输送药物、液体、营养物质或采集血液样本。 CVC 通常用于重症患者或接受化疗或透析等长期治疗的患者。 CVC 专为长期进入中心静脉系统而设计，是周边静脉管线的安全替代方案。其使用有感染疾病、血栓症等风险，需谨慎管理。

据世界卫生组织 (WHO) 称，每年约有 3000 万人被诊断患有败血症。

慢性病增加

越来越多的癌症、心血管疾病和肾臟疾病等慢性疾病往往需要化疗、透析、静脉输液等长期治疗，而CVC则扮演重要角色。随着世界人口的增加，这些慢性疾病的盛行率也增加，进一步推动了需求。此外，CVC 技术的进步提供了更高的安全性和效率，也有助于其采用率的提高。医疗保健系统越来越关注重症加护，并进一步加速 CVC 的使用。患者数量的增加以及对专业医疗护理的需求正在推动市场的成长。

感染和併发症的风险

感染疾病和併发症（例如导管相关血流感染疾病(CRBSI) 和血栓症）的风险会导致住院时间延长、医疗费用增加以及患者发病率增加。因此，医疗保健提供者在使用 CVC 时可能会持谨慎态度，这可能会限制其采用。此外，严格的感染控制规定和专门培训的需要使 CVC 的实施更加复杂。因安全问题而召回的产品也对市场信心产生负面影响。儘管在抗感染设计方面取得了创新，这些风险仍然是一个主要障碍。

产品创新

抗菌涂层等产品创新有助于降低感染风险，并解决与使用 CVC 相关的主要问题之一。此外，更耐用、更易于使用的导管的开发正在改善患者的治疗效果和医疗服务提供者的满意度。导管材料的进步提高了灵活性和生物相容性，也有助于长期使用。这些创新不仅推动了市场成长，而且还促进了重症加护环境中对安全有效的医疗设备的需求不断增长。因此，医疗保健提供者将发现更容易采用新技术，从而进一步扩大市场。

成本和医疗保健预算限制

CVC 设备及其插入程序相关的高成本限制了其采用，特别是在资源匮乏的环境中。医院预算限制可能会优先考虑基本治疗，并减少对 CVC 等先进医疗设备的拨款。此外，医院可能会选择更便宜的替代方案，这可能会影响患者照护的品质。对具有成本效益的解决方案和资源最佳化的需求不断增长，给 CVC 市场带来了压力。购买高品质的导管可能很困难，尤其是对于新兴市场的医院而言。这可能会推迟更新、更有效的 CVC 技术的采用。

COVID-19 的影响

COVID-19 大流行中央静脉导管(CVC) 市场产生了重大影响，导致供应链中断、选择性手术延迟以及医疗重点转向 COVID-19 治疗。这减少了对非紧急医疗程序的需求，并影响了 CVC 在医院的使用。然而，疫情增加了重症患者对重症监护和长期照护的需求，创造了对 CVC 的需求。随着医疗保健系统在大流行后适应，市场正在復苏，并重新关注安全和感染预防。

抗菌导管领域预计将成为预测期内最大的市场

由于与传统导管相关的感染风险不断增加，抗菌导管部分预计将出现良好的成长。这些专用导管涂有抗菌剂，减少了感染的机会，这是医疗保健提供者主要关心的问题。随着医院寻求提高病患安全，对抗菌 CVC 的需求不断增加。此外，这些导管透过减少医疗相关感染来改善患者的治疗效果，最终降低治疗成本。抗菌涂料的技术进步进一步推动了市场的成长。

预计专科诊所产业在预测期内复合年增长率最高

透过为癌症、心血管疾病和肾臟疾病等慢性疾病提供重点治疗，预计专科诊所业务在预测期内将实现最高的复合年增长率。这些诊所提供化疗和透析等量身定制的治疗方法，而 CVC 对于长期药物治疗至关重要。此类疾病的日益普及刺激了对专业持续照护的需求，并推动了 CVC 的使用。此外，这些诊所通常配备先进的设备和医疗专业知识，确保更安全地使用 CVC。由于患者数量的增加和医疗基础设施的改善，专科诊所已成为推动市场扩张的关键领域。随着更多专科诊所的出现，尤其是在新兴市场，这一趋势预计将持续下去。

比最大的地区

由于癌症、心血管疾病和肾臟疾病等慢性病盛行率上升，预计亚太地区在预测期内将占据最大的市场占有率。在中国、印度和日本等国家，专科诊所和医疗机构数量的增加以及重症加护治疗机会的改善进一步增加了对 CVC 的需求。此外，医疗基础设施的改善和先进医疗意识的提高正在推动市场扩张。因此，亚太地区预计将在未来几年为全球 CVC 市场的成长做出重大贡献。

复合年增长率最高的地区：

由于癌症、心血管疾病和肾臟疾病等慢性病的盛行率很高，预计北美在预测期内的复合年增长率最高。北美医疗保健基础设施的发展以及专科诊所和医院的增加也推动了对 CVC 的需求。此外，降低感染风险和改善病患治疗效果的导管设计创新也在推动市场发展。人口老化和化疗和透析等长期治疗的使用增加正在进一步推动市场扩张。监管标准和成熟的医疗保健系统预计将维持这一成长轨迹。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争标基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球中央静脉导管市场：依产品

  • 隧道导管
  • 非隧道导管

第六章全球中央静脉导管市场：依特征

  • 抗菌导管
  • 非抗菌导管

第七章全球中央静脉导管市场：设计

  • 单腔
  • 双腔
  • 多重腔

第八章全球中央静脉导管市场：依构成

  • 聚氨酯
  • 聚四氟乙烯
  • 硅橡胶
  • 其他作品

第九章全球中央静脉导管市场：依最终使用者分类

  • 医院
  • 门诊手术中心
  • 专科诊所
  • 癌症研究所
  • 其他最终用户

第十章全球中央静脉导管市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十一章 主要进展

  • 合约、伙伴关係、合作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十二章 公司概况

  • ICU Medical, Inc.
  • B. Braun SE
  • Becton, Dickinson and Company
  • Poly Medicure Ltd.
  • Lepu Medical Technology Co., Ltd.
  • Teleflex Incorporated
  • VOGT Medical
  • ZOLL Medical Corporation
  • EETA Surgical
  • QMD
  • Kimal
  • Medtronic
  • Rex Medical, LLC
  • Asahi Kasei Corporation
  • AngioDynamics, Inc.
Product Code: SMRC28042

According to Stratistics MRC, the Global Central Venous Catheter Market is accounted for $2861.0 million in 2024 and is expected to reach $4693.5 million by 2030 growing at a CAGR of 8.6% during the forecast period. A Central Venous Catheter (CVC) is a medical device inserted into a large vein, often in the neck, chest, or groin, to deliver medications, fluids, or nutrients, or to collect blood samples. It is commonly used in critically ill patients or those undergoing prolonged treatments such as chemotherapy or dialysis. CVCs are designed for long-term access to the central venous system, offering a safer alternative to peripheral intravenous lines. Their use carries risks such as infection or thrombosis, requiring careful management.

According to the World Health Organization (WHO) approximately 30 million people are diagnosed every year with sepsis.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

The rising prevalence of chronic diseases, such as cancer, cardiovascular disorders, and kidney diseases, often require long-term treatment such as chemotherapy, dialysis, or intravenous medicine, where CVCs are crucial. As the global population increases, the incidence of these chronic conditions increases further boosts demand. Additionally, advancements in CVC technology, offering better safety and efficiency, have contributed to their growing adoption. Healthcare systems are focusing more on critical care, further accelerating the use of CVCs. The combination of higher patient volumes and the need for specialized medical care propels market growth.

Restraint:

Risk of infection and complications

The risk of infection and complications, such as catheter-related bloodstream infections (CRBSIs) and thrombosis, can lead to longer hospital stays, increased healthcare costs, and patient morbidity. As a result, healthcare providers are cautious about CVC usage, which may limit their adoption. Moreover, stringent infection control regulations and the need for specialized training further complicate CVC implementation. Product recalls due to safety concerns also negatively affect market confidence. Despite innovations in infection-resistant designs, these risks remain a significant barrier.

Opportunity:

Product innovation

Product innovation such as those with antimicrobial coatings, help reduce infection risks, addressing one of the major concerns associated with CVC use. Additionally, the development of more durable and user-friendly catheters has improved patient outcomes and healthcare provider satisfaction. Advances in catheter materials, making them more flexible and biocompatible, also contribute to longer-term usage. These innovations not only drive market growth but also help meet the increasing demand for safe, effective medical devices in critical care settings. As a result, healthcare providers are more likely to adopt new technologies, further expanding the market.

Threat:

Cost and healthcare budget constraints

High costs associated with CVC devices and their insertion procedures limit their adoption, especially in low-resource settings. Budget constraints in hospitals can lead to prioritization of essential treatments, reducing the allocation for advanced medical devices like CVCs. Additionally; hospitals may opt for cheaper alternatives, potentially compromising patient care quality. The increasing need for cost-efficient solutions and resource optimization adds pressure on the CVC market. Hospitals, particularly in emerging markets, may struggle with the affordability of high-quality catheters. This can slow down the adoption of newer, more effective CVC technologies.

Covid-19 Impact

The COVID-19 pandemic significantly impacted the central venous catheter (CVC) market, leading to supply chain disruptions, delays in elective procedures, and a shift in healthcare priorities toward COVID-19 treatment. This reduced the demand for non-urgent medical procedures, affecting CVC usage in hospitals. However, the pandemic also increased the need for critical care and long-term treatments in severely ill patients, creating demand for CVCs. As the healthcare system adapts post-pandemic, the market is recovering with renewed focus on safety and infection prevention.

The antimicrobial catheters segment is expected to be the largest during the forecast period

The antimicrobial catheters segment is estimated to have a lucrative growth, due to the increasing risk of infections associated with traditional catheters. These specialized catheters are coated with antimicrobial agents that reduce the likelihood of infections, a major concern for healthcare providers. As hospitals aim to enhance patient safety, the demand for antimicrobial CVCs is rising. Additionally, these catheters improve patient outcomes by lowering healthcare-associated infections, which ultimately reduces treatment costs. Technological advancements in antimicrobial coatings further boost market growth.

The specialized clinics segment is expected to have the highest CAGR during the forecast period

The specialized clinics segment is anticipated to witness the highest CAGR growth during the forecast period, by offering focused care for chronic conditions like cancer, cardiovascular diseases, and kidney disorders. These clinics provide tailored treatments, including chemotherapy and dialysis, where CVCs are essential for long-term medication administration. The increased prevalence of such conditions fuels the demand for specialized, continuous care, boosting the use of CVCs. Furthermore, these clinics often have advanced facilities and medical expertise, ensuring safer CVC usage. With rising patient numbers and improved healthcare infrastructure, specialized clinics are a key segment propelling market expansion. This trend is expected to continue, particularly as more specialized clinics emerge in emerging markets.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period driven by the rising prevalence of chronic diseases like cancer, cardiovascular diseases, and kidney disorders. The increasing number of specialized clinics and healthcare facilities in countries such as China, India, and Japan is enhancing access to critical care treatments, further boosting CVC demand. Additionally, improvements in healthcare infrastructure and rising awareness about advanced medical treatments are propelling market expansion. As a result, Asia-Pacific is expected to be a key contributor to the global CVC market's growth in the coming years.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to the region's high prevalence of chronic diseases like cancer, cardiovascular disorders, and kidney conditions. Advanced healthcare infrastructure and the increasing number of specialized clinics and hospitals in North America also boost demand for CVCs. Additionally, technological innovations in catheter design, which reduce infection risks and improve patient outcomes, are propelling the market. The aging population and the growing number of long-term treatments, such as chemotherapy and dialysis, further support market expansion. Regulatory standards and a well-established healthcare system are expected to sustain this growth trajectory.

Key players in the market

Some of the key players profiled in the Central Venous Catheter Market include ICU Medical, Inc., B. Braun SE, Becton, Dickinson and Company, Poly Medicure Ltd., Lepu Medical Technology Co., Ltd., Teleflex Incorporated, VOGT Medical, ZOLL Medical Corporation, EETA Surgical, QMD, Kimal, Medtronic, Rex Medical, LLC, Asahi Kasei Corporation and AngioDynamics, Inc.

Key Developments:

In November 2024, ICU Medical announced the creation of a joint venture with Otsuka Pharmaceutical Factory, Inc. This collaboration aims to enhance IV solutions manufacturing and innovation in North America.

In June 2024, B. Braun sold its global orthobiologics business, including TETEC AG in Germany and Aesculap Biologics LLC in the U.S., to Octane Medical Group. This transfer included products such as NOVOCART 3D and NOVOCART Inject, which are innovative cartilage repair solutions.

In May 2024, B. Braun introduced the Flexiva TractSeal Mini Fiber in May 2024. This innovative product is designed for minimally invasive laser lithotripsy, ensuring efficiency in urinary stone treatment. It highlights B. Braun's commitment to expanding its minimally invasive medical technologies portfolio.

Products Covered:

  • Tunneled Catheters
  • Non-Tunneled Catheters

Properties Covered:

  • Antimicrobial Catheters
  • Non-Antimicrobial Catheters

Designs Covered:

  • Single Lumen
  • Double Lumen
  • Multiple Lumen

Compositions Covered:

  • Polyurethane
  • Teflon
  • Silicone Rubber
  • Other Compositions

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics
  • Cancer Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Central Venous Catheter Market, By Product

  • 5.1 Introduction
  • 5.2 Tunneled Catheters
  • 5.3 Non-Tunneled Catheters

6 Global Central Venous Catheter Market, By Property

  • 6.1 Introduction
  • 6.2 Antimicrobial Catheters
  • 6.3 Non-Antimicrobial Catheters

7 Global Central Venous Catheter Market, By Design

  • 7.1 Introduction
  • 7.2 Single Lumen
  • 7.3 Double Lumen
  • 7.4 Multiple Lumen

8 Global Central Venous Catheter Market, By Composition

  • 8.1 Introduction
  • 8.2 Polyurethane
  • 8.3 Teflon
  • 8.4 Silicone Rubber
  • 8.5 Other Compositions

9 Global Central Venous Catheter Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Ambulatory Surgical Centers
  • 9.4 Specialized Clinics
  • 9.5 Cancer Research Institutes
  • 9.6 Other End Users

10 Global Central Venous Catheter Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 ICU Medical, Inc.
  • 12.2 B. Braun SE
  • 12.3 Becton, Dickinson and Company
  • 12.4 Poly Medicure Ltd.
  • 12.5 Lepu Medical Technology Co., Ltd.
  • 12.6 Teleflex Incorporated
  • 12.7 VOGT Medical
  • 12.8 ZOLL Medical Corporation
  • 12.9 EETA Surgical
  • 12.10 QMD
  • 12.11 Kimal
  • 12.12 Medtronic
  • 12.12 Rex Medical, LLC
  • 12.14 Asahi Kasei Corporation
  • 12.15 AngioDynamics, Inc.

List of Tables

  • Table 1 Global Central Venous Catheter Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Central Venous Catheter Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Central Venous Catheter Market Outlook, By Tunneled Catheters (2022-2030) ($MN)
  • Table 4 Global Central Venous Catheter Market Outlook, By Non-Tunneled Catheters (2022-2030) ($MN)
  • Table 5 Global Central Venous Catheter Market Outlook, By Property (2022-2030) ($MN)
  • Table 6 Global Central Venous Catheter Market Outlook, By Antimicrobial Catheters (2022-2030) ($MN)
  • Table 7 Global Central Venous Catheter Market Outlook, By Non-Antimicrobial Catheters (2022-2030) ($MN)
  • Table 8 Global Central Venous Catheter Market Outlook, By Design (2022-2030) ($MN)
  • Table 9 Global Central Venous Catheter Market Outlook, By Single Lumen (2022-2030) ($MN)
  • Table 10 Global Central Venous Catheter Market Outlook, By Double Lumen (2022-2030) ($MN)
  • Table 11 Global Central Venous Catheter Market Outlook, By Multiple Lumen (2022-2030) ($MN)
  • Table 12 Global Central Venous Catheter Market Outlook, By Composition (2022-2030) ($MN)
  • Table 13 Global Central Venous Catheter Market Outlook, By Polyurethane (2022-2030) ($MN)
  • Table 14 Global Central Venous Catheter Market Outlook, By Teflon (2022-2030) ($MN)
  • Table 15 Global Central Venous Catheter Market Outlook, By Silicone Rubber (2022-2030) ($MN)
  • Table 16 Global Central Venous Catheter Market Outlook, By Other Compositions (2022-2030) ($MN)
  • Table 17 Global Central Venous Catheter Market Outlook, By End User (2022-2030) ($MN)
  • Table 18 Global Central Venous Catheter Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 19 Global Central Venous Catheter Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 20 Global Central Venous Catheter Market Outlook, By Specialized Clinics (2022-2030) ($MN)
  • Table 21 Global Central Venous Catheter Market Outlook, By Cancer Research Institutes (2022-2030) ($MN)
  • Table 22 Global Central Venous Catheter Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 23 North America Central Venous Catheter Market Outlook, By Country (2022-2030) ($MN)
  • Table 24 North America Central Venous Catheter Market Outlook, By Product (2022-2030) ($MN)
  • Table 25 North America Central Venous Catheter Market Outlook, By Tunneled Catheters (2022-2030) ($MN)
  • Table 26 North America Central Venous Catheter Market Outlook, By Non-Tunneled Catheters (2022-2030) ($MN)
  • Table 27 North America Central Venous Catheter Market Outlook, By Property (2022-2030) ($MN)
  • Table 28 North America Central Venous Catheter Market Outlook, By Antimicrobial Catheters (2022-2030) ($MN)
  • Table 29 North America Central Venous Catheter Market Outlook, By Non-Antimicrobial Catheters (2022-2030) ($MN)
  • Table 30 North America Central Venous Catheter Market Outlook, By Design (2022-2030) ($MN)
  • Table 31 North America Central Venous Catheter Market Outlook, By Single Lumen (2022-2030) ($MN)
  • Table 32 North America Central Venous Catheter Market Outlook, By Double Lumen (2022-2030) ($MN)
  • Table 33 North America Central Venous Catheter Market Outlook, By Multiple Lumen (2022-2030) ($MN)
  • Table 34 North America Central Venous Catheter Market Outlook, By Composition (2022-2030) ($MN)
  • Table 35 North America Central Venous Catheter Market Outlook, By Polyurethane (2022-2030) ($MN)
  • Table 36 North America Central Venous Catheter Market Outlook, By Teflon (2022-2030) ($MN)
  • Table 37 North America Central Venous Catheter Market Outlook, By Silicone Rubber (2022-2030) ($MN)
  • Table 38 North America Central Venous Catheter Market Outlook, By Other Compositions (2022-2030) ($MN)
  • Table 39 North America Central Venous Catheter Market Outlook, By End User (2022-2030) ($MN)
  • Table 40 North America Central Venous Catheter Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 41 North America Central Venous Catheter Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 42 North America Central Venous Catheter Market Outlook, By Specialized Clinics (2022-2030) ($MN)
  • Table 43 North America Central Venous Catheter Market Outlook, By Cancer Research Institutes (2022-2030) ($MN)
  • Table 44 North America Central Venous Catheter Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 45 Europe Central Venous Catheter Market Outlook, By Country (2022-2030) ($MN)
  • Table 46 Europe Central Venous Catheter Market Outlook, By Product (2022-2030) ($MN)
  • Table 47 Europe Central Venous Catheter Market Outlook, By Tunneled Catheters (2022-2030) ($MN)
  • Table 48 Europe Central Venous Catheter Market Outlook, By Non-Tunneled Catheters (2022-2030) ($MN)
  • Table 49 Europe Central Venous Catheter Market Outlook, By Property (2022-2030) ($MN)
  • Table 50 Europe Central Venous Catheter Market Outlook, By Antimicrobial Catheters (2022-2030) ($MN)
  • Table 51 Europe Central Venous Catheter Market Outlook, By Non-Antimicrobial Catheters (2022-2030) ($MN)
  • Table 52 Europe Central Venous Catheter Market Outlook, By Design (2022-2030) ($MN)
  • Table 53 Europe Central Venous Catheter Market Outlook, By Single Lumen (2022-2030) ($MN)
  • Table 54 Europe Central Venous Catheter Market Outlook, By Double Lumen (2022-2030) ($MN)
  • Table 55 Europe Central Venous Catheter Market Outlook, By Multiple Lumen (2022-2030) ($MN)
  • Table 56 Europe Central Venous Catheter Market Outlook, By Composition (2022-2030) ($MN)
  • Table 57 Europe Central Venous Catheter Market Outlook, By Polyurethane (2022-2030) ($MN)
  • Table 58 Europe Central Venous Catheter Market Outlook, By Teflon (2022-2030) ($MN)
  • Table 59 Europe Central Venous Catheter Market Outlook, By Silicone Rubber (2022-2030) ($MN)
  • Table 60 Europe Central Venous Catheter Market Outlook, By Other Compositions (2022-2030) ($MN)
  • Table 61 Europe Central Venous Catheter Market Outlook, By End User (2022-2030) ($MN)
  • Table 62 Europe Central Venous Catheter Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 63 Europe Central Venous Catheter Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 64 Europe Central Venous Catheter Market Outlook, By Specialized Clinics (2022-2030) ($MN)
  • Table 65 Europe Central Venous Catheter Market Outlook, By Cancer Research Institutes (2022-2030) ($MN)
  • Table 66 Europe Central Venous Catheter Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 67 Asia Pacific Central Venous Catheter Market Outlook, By Country (2022-2030) ($MN)
  • Table 68 Asia Pacific Central Venous Catheter Market Outlook, By Product (2022-2030) ($MN)
  • Table 69 Asia Pacific Central Venous Catheter Market Outlook, By Tunneled Catheters (2022-2030) ($MN)
  • Table 70 Asia Pacific Central Venous Catheter Market Outlook, By Non-Tunneled Catheters (2022-2030) ($MN)
  • Table 71 Asia Pacific Central Venous Catheter Market Outlook, By Property (2022-2030) ($MN)
  • Table 72 Asia Pacific Central Venous Catheter Market Outlook, By Antimicrobial Catheters (2022-2030) ($MN)
  • Table 73 Asia Pacific Central Venous Catheter Market Outlook, By Non-Antimicrobial Catheters (2022-2030) ($MN)
  • Table 74 Asia Pacific Central Venous Catheter Market Outlook, By Design (2022-2030) ($MN)
  • Table 75 Asia Pacific Central Venous Catheter Market Outlook, By Single Lumen (2022-2030) ($MN)
  • Table 76 Asia Pacific Central Venous Catheter Market Outlook, By Double Lumen (2022-2030) ($MN)
  • Table 77 Asia Pacific Central Venous Catheter Market Outlook, By Multiple Lumen (2022-2030) ($MN)
  • Table 78 Asia Pacific Central Venous Catheter Market Outlook, By Composition (2022-2030) ($MN)
  • Table 79 Asia Pacific Central Venous Catheter Market Outlook, By Polyurethane (2022-2030) ($MN)
  • Table 80 Asia Pacific Central Venous Catheter Market Outlook, By Teflon (2022-2030) ($MN)
  • Table 81 Asia Pacific Central Venous Catheter Market Outlook, By Silicone Rubber (2022-2030) ($MN)
  • Table 82 Asia Pacific Central Venous Catheter Market Outlook, By Other Compositions (2022-2030) ($MN)
  • Table 83 Asia Pacific Central Venous Catheter Market Outlook, By End User (2022-2030) ($MN)
  • Table 84 Asia Pacific Central Venous Catheter Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 85 Asia Pacific Central Venous Catheter Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 86 Asia Pacific Central Venous Catheter Market Outlook, By Specialized Clinics (2022-2030) ($MN)
  • Table 87 Asia Pacific Central Venous Catheter Market Outlook, By Cancer Research Institutes (2022-2030) ($MN)
  • Table 88 Asia Pacific Central Venous Catheter Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 89 South America Central Venous Catheter Market Outlook, By Country (2022-2030) ($MN)
  • Table 90 South America Central Venous Catheter Market Outlook, By Product (2022-2030) ($MN)
  • Table 91 South America Central Venous Catheter Market Outlook, By Tunneled Catheters (2022-2030) ($MN)
  • Table 92 South America Central Venous Catheter Market Outlook, By Non-Tunneled Catheters (2022-2030) ($MN)
  • Table 93 South America Central Venous Catheter Market Outlook, By Property (2022-2030) ($MN)
  • Table 94 South America Central Venous Catheter Market Outlook, By Antimicrobial Catheters (2022-2030) ($MN)
  • Table 95 South America Central Venous Catheter Market Outlook, By Non-Antimicrobial Catheters (2022-2030) ($MN)
  • Table 96 South America Central Venous Catheter Market Outlook, By Design (2022-2030) ($MN)
  • Table 97 South America Central Venous Catheter Market Outlook, By Single Lumen (2022-2030) ($MN)
  • Table 98 South America Central Venous Catheter Market Outlook, By Double Lumen (2022-2030) ($MN)
  • Table 99 South America Central Venous Catheter Market Outlook, By Multiple Lumen (2022-2030) ($MN)
  • Table 100 South America Central Venous Catheter Market Outlook, By Composition (2022-2030) ($MN)
  • Table 101 South America Central Venous Catheter Market Outlook, By Polyurethane (2022-2030) ($MN)
  • Table 102 South America Central Venous Catheter Market Outlook, By Teflon (2022-2030) ($MN)
  • Table 103 South America Central Venous Catheter Market Outlook, By Silicone Rubber (2022-2030) ($MN)
  • Table 104 South America Central Venous Catheter Market Outlook, By Other Compositions (2022-2030) ($MN)
  • Table 105 South America Central Venous Catheter Market Outlook, By End User (2022-2030) ($MN)
  • Table 106 South America Central Venous Catheter Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 107 South America Central Venous Catheter Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 108 South America Central Venous Catheter Market Outlook, By Specialized Clinics (2022-2030) ($MN)
  • Table 109 South America Central Venous Catheter Market Outlook, By Cancer Research Institutes (2022-2030) ($MN)
  • Table 110 South America Central Venous Catheter Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 111 Middle East & Africa Central Venous Catheter Market Outlook, By Country (2022-2030) ($MN)
  • Table 112 Middle East & Africa Central Venous Catheter Market Outlook, By Product (2022-2030) ($MN)
  • Table 113 Middle East & Africa Central Venous Catheter Market Outlook, By Tunneled Catheters (2022-2030) ($MN)
  • Table 114 Middle East & Africa Central Venous Catheter Market Outlook, By Non-Tunneled Catheters (2022-2030) ($MN)
  • Table 115 Middle East & Africa Central Venous Catheter Market Outlook, By Property (2022-2030) ($MN)
  • Table 116 Middle East & Africa Central Venous Catheter Market Outlook, By Antimicrobial Catheters (2022-2030) ($MN)
  • Table 117 Middle East & Africa Central Venous Catheter Market Outlook, By Non-Antimicrobial Catheters (2022-2030) ($MN)
  • Table 118 Middle East & Africa Central Venous Catheter Market Outlook, By Design (2022-2030) ($MN)
  • Table 119 Middle East & Africa Central Venous Catheter Market Outlook, By Single Lumen (2022-2030) ($MN)
  • Table 120 Middle East & Africa Central Venous Catheter Market Outlook, By Double Lumen (2022-2030) ($MN)
  • Table 121 Middle East & Africa Central Venous Catheter Market Outlook, By Multiple Lumen (2022-2030) ($MN)
  • Table 122 Middle East & Africa Central Venous Catheter Market Outlook, By Composition (2022-2030) ($MN)
  • Table 123 Middle East & Africa Central Venous Catheter Market Outlook, By Polyurethane (2022-2030) ($MN)
  • Table 124 Middle East & Africa Central Venous Catheter Market Outlook, By Teflon (2022-2030) ($MN)
  • Table 125 Middle East & Africa Central Venous Catheter Market Outlook, By Silicone Rubber (2022-2030) ($MN)
  • Table 126 Middle East & Africa Central Venous Catheter Market Outlook, By Other Compositions (2022-2030) ($MN)
  • Table 127 Middle East & Africa Central Venous Catheter Market Outlook, By End User (2022-2030) ($MN)
  • Table 128 Middle East & Africa Central Venous Catheter Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 129 Middle East & Africa Central Venous Catheter Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 130 Middle East & Africa Central Venous Catheter Market Outlook, By Specialized Clinics (2022-2030) ($MN)
  • Table 131 Middle East & Africa Central Venous Catheter Market Outlook, By Cancer Research Institutes (2022-2030) ($MN)
  • Table 132 Middle East & Africa Central Venous Catheter Market Outlook, By Other End Users (2022-2030) ($MN)